SAN CARLOS, Calif. (AP) _ Iovance Biotherapeutics Inc. (IOVA) on Thursday reported a loss of $81.4 million in its second quarter.

On a per-share basis, the San Carlos, California-based company said it had a loss of 53 cents.

The results missed Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of 52 cents per share.

Iovance Biotherapeutics shares have fallen 48% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $23.93, a decrease of 22% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IOVA at https://www.zacks.com/ap/IOVA

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News